A detailed history of Empirical Finance, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Empirical Finance, LLC holds 2,416 shares of WST stock, worth $807,572. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,416
Previous 2,359 2.42%
Holding current value
$807,572
Previous $777,000 6.69%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$277.16 - $333.3 $15,798 - $18,998
57 Added 2.42%
2,416 $725,000
Q2 2024

Jul 30, 2024

SELL
$314.68 - $395.94 $46,257 - $58,203
-147 Reduced 5.87%
2,359 $777,000
Q1 2024

May 06, 2024

BUY
$338.27 - $413.0 $37,886 - $46,256
112 Added 4.68%
2,506 $991,000
Q3 2023

Nov 02, 2023

BUY
$354.9 - $412.41 $83,756 - $97,328
236 Added 10.94%
2,394 $898,000
Q2 2023

Jul 27, 2023

BUY
$334.63 - $382.47 $93,361 - $106,709
279 Added 14.85%
2,158 $825,000
Q1 2023

Apr 05, 2023

BUY
$232.5 - $346.47 $19,762 - $29,449
85 Added 4.74%
1,879 $651,000
Q4 2022

Jan 24, 2023

BUY
$209.34 - $261.61 $32,866 - $41,072
157 Added 9.59%
1,794 $422,000
Q3 2022

Nov 04, 2022

BUY
$246.08 - $343.65 $73,331 - $102,407
298 Added 22.26%
1,637 $403,000
Q2 2022

Aug 01, 2022

BUY
$280.61 - $420.45 $21,045 - $31,533
75 Added 5.93%
1,339 $405,000
Q1 2022

Apr 21, 2022

BUY
$357.49 - $445.92 $54,695 - $68,225
153 Added 13.77%
1,264 $519,000
Q4 2021

Feb 04, 2022

BUY
$402.25 - $471.34 $144,005 - $168,739
358 Added 47.54%
1,111 $521,000
Q3 2021

Nov 12, 2021

BUY
$363.01 - $468.47 $21,417 - $27,639
59 Added 8.5%
753 $320,000
Q2 2021

Aug 10, 2021

BUY
$284.77 - $363.2 $197,630 - $252,060
694 New
694 $249,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.